1. Home
  2. VERA vs SAM Comparison

VERA vs SAM Comparison

Compare VERA & SAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • SAM
  • Stock Information
  • Founded
  • VERA 2016
  • SAM 1984
  • Country
  • VERA United States
  • SAM United States
  • Employees
  • VERA N/A
  • SAM N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • SAM Beverages (Production/Distribution)
  • Sector
  • VERA Health Care
  • SAM Consumer Staples
  • Exchange
  • VERA Nasdaq
  • SAM Nasdaq
  • Market Cap
  • VERA 2.0B
  • SAM 2.1B
  • IPO Year
  • VERA 2021
  • SAM 1995
  • Fundamental
  • Price
  • VERA $23.82
  • SAM $194.63
  • Analyst Decision
  • VERA Buy
  • SAM Hold
  • Analyst Count
  • VERA 8
  • SAM 11
  • Target Price
  • VERA $64.63
  • SAM $271.70
  • AVG Volume (30 Days)
  • VERA 1.4M
  • SAM 298.7K
  • Earning Date
  • VERA 08-07-2025
  • SAM 07-24-2025
  • Dividend Yield
  • VERA N/A
  • SAM N/A
  • EPS Growth
  • VERA N/A
  • SAM N/A
  • EPS
  • VERA N/A
  • SAM 6.16
  • Revenue
  • VERA N/A
  • SAM $2,040,741,000.00
  • Revenue This Year
  • VERA N/A
  • SAM $2.79
  • Revenue Next Year
  • VERA N/A
  • SAM $2.61
  • P/E Ratio
  • VERA N/A
  • SAM $31.63
  • Revenue Growth
  • VERA N/A
  • SAM 0.79
  • 52 Week Low
  • VERA $18.53
  • SAM $185.34
  • 52 Week High
  • VERA $51.61
  • SAM $329.55
  • Technical
  • Relative Strength Index (RSI)
  • VERA 52.93
  • SAM 38.19
  • Support Level
  • VERA $22.57
  • SAM $191.44
  • Resistance Level
  • VERA $24.58
  • SAM $200.54
  • Average True Range (ATR)
  • VERA 1.22
  • SAM 6.64
  • MACD
  • VERA 0.14
  • SAM 1.26
  • Stochastic Oscillator
  • VERA 69.80
  • SAM 40.94

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About SAM Boston Beer Company Inc. (The)

Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates almost all sales in the US.

Share on Social Networks: